Acute coronary syndromes undergoing percutaneous coronary intervention in the COVID-19 era: comparable case volumes but delayed symptom onset to hospital presentation

Toner, Liam; Koshy, A.; Hamilton, Glen W.; Clark, David; Farouque, Omar; Yudi, M.

doi:10.1093/ehjqcco/qcaa038

Cited by 45 publications

(54 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…(b) Older patients with an ACS (mainly UA) presented less frequently to the hospitals during the COVID‐19 period; older patients were considered from the start of the outbreak as one of the population groups at highest risk from COVID‐19 and were urged early by mass media and government authorities to avoid social contact and be self‐confined. (c) During the COVID‐19 outbreak, ACS patients presented more frequently with LV systolic impairment, which may serve as a surrogate marker for delayed MI presentation, and is supported by longer times from symptom onset to first medical contact observed for MI patients in other countries 9‐11 …”

Section: Discussionmentioning

confidence: 95%

“Missing” acute coronary syndrome hospitalizations during the COVID‐19 era in Greece: Medical care avoidance combined with a true reduction in incidence?

Papafaklis

Katsouras

Tsigkas

et al. 2020

Clinical Cardiology

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 95%

“Missing” acute coronary syndrome hospitalizations during the COVID‐19 era in Greece: Medical care avoidance combined with a true reduction in incidence?

Papafaklis

Katsouras

Tsigkas

et al. 2020

Clinical Cardiology

View full text Add to dashboard Cite

show abstract

“…1). 5 Moreover, approximately one in two patients presented over 12 h following symptom onset. This is of significant concern due to the consequences posed by the delayed treatment of acute myocardial infarction.…”

mentioning

confidence: 99%

“…As such, forethought must be given to the establishment of hospital systems to meet the growing needs of patients who have been overshadowed by the threat of this pandemic. Reproduced from Toner et al, 5 with permission.…”

mentioning

confidence: 99%

Collateral damage of a global pandemic: implications of COVID‐19 for Australians with cardiovascular disease

Murphy

Koshy

Yudi

2020

Internal Medicine Journal

View full text Add to dashboard Cite

“…Variations in demographics and population of selected patients, together with small samples, may explain differences observed in other health services. 21 The framework presented in this manuscript may be used for further research into other conditions and monitor effect of the SOE over the next coming months. More granular assessment of times would mandate separation of different acute reperfusion interventions, with comparison of times for specific procedures.…”

Section: Discussionmentioning

confidence: 99%

Presentations of stroke and acute myocardial infarction in the first 28 days following the introduction of State of Emergency restrictions for COVID‐19

Mitra

Mitchell

Cloud

et al. 2020

Emerg Medicine Australasia

View full text Add to dashboard Cite

Objectives: To determine if Victorian State of Emergency (SOE) measures to combat COVID-19 were associated with delayed presentations or management of acute stroke and acute myocardial infarction (AMI). Methods: This was a retrospective, pre-and post-implementation study using data from an adult, tertiary cardiology and neurosciences centre with 24-h capacity for endovascular procedures. All primary presentations with acute stroke or AMI during the first 28 days of stage 2 and stage 3 SOE restrictions (26 March to 23 April 2020) were compared to an equivalent period without restrictions (26 March to 23 April 2019). The primary outcome variable was time from onset of symptoms to ED presentation. Results: There were 52 (1.6% of all ED presentations) patients who met inclusion criteria during the SOE period and 57 (1.0%) patients in the comparator period. Patients were equally matched for demographics, disease severity and prior history of stroke or AMI. Median time from symptom onset to presentation was 227 (93-1183) min during the SOE period and 342 (119-1220) min during the comparator period (P = 0.24). Among eligible patients with ischaemic stroke or ST-elevation AMI, median time to primary reperfusion intervention was 65 (37-78) min during SOE and 44 (39-60) min in the comparator period (P = 0.54). There were no differences in mortality at hospital discharge (9.6% vs 10.5%) and hospital length of stay (5.4 vs 4.3 days). Conclusions: In the first 28 days, SOE measures to combat COVID-19 were not associated with delays in presentation or life-saving interventions for patients with acute stroke and AMI.

show abstract

Acute coronary syndromes undergoing percutaneous coronary intervention in the COVID-19 era: comparable case volumes but delayed symptom onset to hospital presentation

Cited by 45 publications

References 5 publications

“Missing” acute coronary syndrome hospitalizations during the COVID‐19 era in Greece: Medical care avoidance combined with a true reduction in incidence?

“Missing” acute coronary syndrome hospitalizations during the COVID‐19 era in Greece: Medical care avoidance combined with a true reduction in incidence?

Collateral damage of a global pandemic: implications of COVID‐19 for Australians with cardiovascular disease

Presentations of stroke and acute myocardial infarction in the first 28 days following the introduction of State of Emergency restrictions for COVID‐19

Contact Info

Product

Resources

About